Harvard Health Blog

Newer drugs are improving survival for men with metastatic prostate cancer

By: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease Treatments for advanced prostate cancer thatís metastasizing, or spreading in the body, are getting better, and men with the disease are living longer because of them, new research has found. For years, the only available treatments for these aggressive tumors were androgen-deprivation therapies (ADT) that block testosterone, the male sex hormone that makes prostate cancer cells grow faster. Giving ADT slows…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In